Brief: Acura Pharmaceutical's Limitx technology successfully demonstrates oral abuse deterrence

Acura Pharmaceuticals

13/04/2016 21:10

April 13 (Reuters) - Acura Pharmaceuticals Inc  ACUR.O  : 
    * Acura pharmaceutical's Limitx(TM) technology successfully 
demonstrates oral abuse deterrence 
    * Says  second cohort of study is expected to commence later 
this month. 
    * Says cohort 2 of study AP-LTX-400 topline results expected 
in late June 2016 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nMKWVwlV2a 
Further company coverage:  ACUR.O  
 
 (Bengaluru Newsroom: +1-646-223-8780)